Back to today’s briefing

Story perspectives

Paramedic Visits Aid Women, Diabetes Drug Cuts Risks

3/30/2025

50 7

Summary

Story summary

The MIGHTy-Heart trial showed that while in-home paramedic visits didn't lower overall 30-day readmissions for heart failure patients, they proved beneficial for women and younger individuals. In contrast, the FRESH-UP trial found fluid restriction ineffective, while the SOUL trial revealed that oral semaglutide cut cardiovascular risks by 14% for those with type 2 diabetes.

1 of 1

Story summary

The MIGHTy-Heart trial showed that while in-home paramedic visits didn't lower overall 30-day readmissions for heart failure patients, they proved beneficial for women and younger individuals. In contrast, the FRESH-UP trial found fluid restriction ineffective, while the SOUL trial revealed that oral semaglutide cut cardiovascular risks by 14% for those with type 2 diabetes.